Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia.

Bradstock KF, Link E, Collins M, Di Iulio J, Lewis ID, Schwarer A, Enno A, Marlton P, Hahn U, Szer J, Cull G, Seymour JF; the Australasian Leukaemia and Lymphoma Group.

Br J Haematol. 2014 Aug 21. doi: 10.1111/bjh.13086. [Epub ahead of print]

PMID:
25142189
[PubMed - as supplied by publisher]
2.

Lymphoplasmacytic hypophysitis associated with immunoglobulin G4.

Khong P, Enno A, Darwish B.

J Clin Neurosci. 2014 Feb;21(2):342-4. doi: 10.1016/j.jocn.2013.02.037. Epub 2013 Aug 17.

PMID:
23962633
[PubMed - in process]
3.

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).

Iland HJ, Bradstock K, Supple SG, Catalano A, Collins M, Hertzberg M, Browett P, Grigg A, Firkin F, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group.

Blood. 2012 Aug 23;120(8):1570-80; quiz 1752. Epub 2012 Jun 19.

PMID:
22715121
[PubMed - indexed for MEDLINE]
Free Article
4.

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.

Pfreundschuh M, Kuhnt E, Trümper L, Osterborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani PL, Shpilberg O, Kvaloy S, de Nully Brown P, Stahel R, Milpied N, López-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N; MabThera International Trial (MInT) Group.

Lancet Oncol. 2011 Oct;12(11):1013-22. doi: 10.1016/S1470-2045(11)70235-2. Epub 2011 Sep 21.

PMID:
21940214
[PubMed - indexed for MEDLINE]
5.

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.

Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR; International Vidaza High-Risk MDS Survival Study Group.

Lancet Oncol. 2009 Mar;10(3):223-32. doi: 10.1016/S1470-2045(09)70003-8. Epub 2009 Feb 21.

PMID:
19230772
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma.

Mitchell PL, Marlton P, Grigg A, Seymour JF, Hertzberg M, Enno A, Herrmann R, Bond R, Arthur C.

Leuk Lymphoma. 2008 May;49(5):924-31. doi: 10.1080/10428190802007700.

PMID:
18464112
[PubMed - indexed for MEDLINE]
7.

Convergence and divergence among multiple methods for assessing adolescent romantic relationships.

Galliher RV, Enno AM, Wright R.

J Adolesc. 2008 Dec;31(6):747-69. doi: 10.1016/j.adolescence.2007.12.003. Epub 2008 Jan 22.

PMID:
18207231
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma.

Au GG, Lincz LF, Enno A, Shafren DR.

Br J Haematol. 2007 Apr;137(2):133-41.

PMID:
17391493
[PubMed - indexed for MEDLINE]
9.

Genetic variations in benzene metabolism and susceptibility to multiple myeloma.

Lincz LF, Scorgie FE, Robertson R, Enno A.

Leuk Res. 2007 Jun;31(6):759-63. Epub 2006 Sep 1.

PMID:
16949155
[PubMed - indexed for MEDLINE]
10.

Hospital in the home (HITH) care following autologous stem cell transplantation for lymphoma and multiple myeloma.

Johnson W, Kerridge I, Milton C, Carr D, Enno A, Bray L, Booth A.

Aust J Adv Nurs. 2006 Jun-Aug;23(4):34-9.

PMID:
16800218
[PubMed - indexed for MEDLINE]
11.

Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of 'Helicobacter heilmannii' infection.

O'Rourke JL, Dixon MF, Jack A, Enno A, Lee A.

J Pathol. 2004 Aug;203(4):896-903.

PMID:
15258991
[PubMed - indexed for MEDLINE]
12.

Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantation.

Lincz LF, Scorgie FE, Sakoff JA, Fagan KA, Ackland SP, Enno A.

Bone Marrow Transplant. 2004 Sep;34(5):439-45.

PMID:
15258557
[PubMed - indexed for MEDLINE]
13.

A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.

Bradstock KF, Matthews JP, Lowenthal RM, Baxter H, Catalano J, Brighton T, Gill D, Eliadis P, Joshua D, Cannell P, Schwarer AP, Durrant S, Gillett A, Koutts J, Taylor K, Bashford J, Arthur C, Enno A, Dunlop L, Szer J, Leahy M, Juneja S, Young GA; Australasian Leukaemia and Lymphoma Group.

Blood. 2005 Jan 15;105(2):481-8. Epub 2004 Jun 22.

PMID:
15213095
[PubMed - indexed for MEDLINE]
Free Article
14.

Induction with oral chemotherapy (CID) followed by early autologous stem cell transplantation for de novo multiple myeloma patients.

Spencer A, Seldon M, Deveridge S, Cobcroft R, Cull G, Marlton P, Enno A, Gill D.

Hematol J. 2004;5(3):216-21.

PMID:
15167907
[PubMed - indexed for MEDLINE]
15.

Xenobiotic gene polymorphisms and susceptibility to multiple myeloma.

Lincz LF, Kerridge I, Scorgie FE, Bailey M, Enno A, Spencer A.

Haematologica. 2004 May;89(5):628-9.

PMID:
15136237
[PubMed - indexed for MEDLINE]
Free Article
16.

Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma.

Lincz LF, Scorgie FE, Kerridge I, Potts R, Spencer A, Enno A.

Br J Haematol. 2003 Mar;120(6):1051-4.

PMID:
12648076
[PubMed - indexed for MEDLINE]
17.

Telomere length in haemopoietic stem cells can be determined from that of mononuclear blood cells or whole blood.

Sakoff JA, De Waal E, Garg MB, Denham J, Scorgie FE, Enno A, Lincz LF, Ackland SP.

Leuk Lymphoma. 2002 Oct;43(10):2017-20.

PMID:
12481901
[PubMed - indexed for MEDLINE]
18.

Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia.

Bradstock K, Matthews J, Young G, Lowenthal R, Baxter H, Arthur C, Bashford J, Brighton T, Cannell P, Dunlop L, Durrant S, Enno A, Eliadis P, Gill D, Gillett A, Gottlieb D, Januszewicz H, Joshua D, Leahy M, Schwarer A, Taylor K; Australian Leukaemia Study Group.

Leukemia. 2001 Sep;15(9):1331-8.

PMID:
11516093
[PubMed - indexed for MEDLINE]
19.

Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia.

Matthews JP, Bishop JF, Young GA, Juneja SK, Lowenthal RM, Garson OM, Cobcroft RG, Dodds AJ, Enno A, Gillett EA, Hermann RP, Joshua DE, Ma DD, Szer J, Taylor KM, Wolf M, Bradstock KF; Australian Leukemia Study Group.

Br J Haematol. 2001 Jun;113(3):727-36.

PMID:
11380464
[PubMed - indexed for MEDLINE]
20.

Helicobacter-induced expression of Bcl-X(L) in B lymphocytes in the mouse model: a possible step in the development of gastric mucosa-associated lymphoid tissue (MALT) lymphoma.

Morgner A, Sutton P, O'Rourke JL, Enno A, Dixon MF, Lee A.

Int J Cancer. 2001 Jun 1;92(5):634-40.

PMID:
11340565
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk